Loading chat...
DE SJR7
Joint Resolution
Status
8/25/2025
Primary Sponsor
Raymond Seigfried
Click for details
AI Summary
-
Directs the State Employee Benefits Committee (SEBC) to own and control all pharmaceutical data, including real-time point-of-sale pricing, to improve transparency and prevent abusive practices by pharmacy benefit managers (PBMs)
-
Recommends establishing an independent Pharmacy and Therapeutics Committee to develop formularies focused on lowest-cost drugs and generic alternatives when therapeutically equivalent
-
Requires PBMs to disclose complete administrative expenses and all agreements with pharmaceutical manufacturers, with the State retaining full audit rights
-
Encourages pursuing interstate compacts to negotiate directly with drug manufacturers for high-priced medications and ensuring the State pays no more than Medicare-negotiated prices
-
Mandates the SEBC submit a report by August 1, 2026, detailing any implementation difficulties in achieving cost-effective prescription drug coverage for state employees and retirees
Legislative Description
Directing The State Employee Benefits Committee And The Secretary Of Human Resources To Engage With Independent Consultants And Other Supply Chain Tactics For Cost Containment Of Prescription Drugs For State Employees And Retirees Insurance Programs.
Last Action
Signed by Governor
8/25/2025